340B Overview: Best Purchasing Practices for Compliance & Benefit

Shawn Wood, MBA, CPHT, 340B ACE, is Director of System 340B Oversight and Compliance for Beth Israel Lahey Health (BILH), overseeing hospitals’ onsite 340B Program or split-billing, 340B advocacy and overall 340B Program compliance. BILH’s 340B program is a large program with significant regulatory, compliance, financial, IS, and workflow complexities that supports its financial health, which he supports.

Shawn has 14 years of experience in the 340B Program and more than 20 years in hospital pharmacy settings. His career began as a pharmacy technician, then pharmacy supply chain and then moved to administering the 340B Program. His 340B expertise spans hospital based and contract pharmacy programs, pharmacy supply chain and includes, a Pharmacy Technician Certification, an advanced certification for 340B or ACE, a Bachelors in Healthcare Management from Cambridge College and an MBA from UMass-Boston. He has also spoken nationally at the 340B Conference on best practice and, twice locally at Massachusetts Society of Health-System Pharmacists (MSHP) on the expanding role of Pharmacy Technicians and the 340B Program. Most recently he received from MSHP the
Technician of the Year Award for his work on Beth Israel Deaconess Medical Center’s 340B Program.

Shawn Wood Overview of "The 340B Program; Overview to Best Practices" Presentation at HCP Rx Buyer's Conference in Summer 2023
Shawn Wood Overview of "The 340B Program; Overview to Best Practices" Presentation at HCP Rx Buyer's Conference in Summer 2023

LEARNING OBJECTIVES:

• Recognize the basics of the 340B Program and identify compliance requirements
• Explain potential workflow issues related to the 340B Program and mitigation strategies
• Summarize purchasing strategies to optimize the 340B Program
• Identify the resources available to support the 340B Program

Latest Videos
View all Videos
Executive Insights
Feb 10, 2025

Michael LaFauci, the CEO of MIDAS Healthcare Solutions, leads a company dedicated to the intelligent disposal and visual accountability of medications. MIDAS aims to ensure proof of final destruction of medications, enhancing safety for both patients and healthcare workers.  With a focus on teamwork and the right talent, MIDAS plans to expand its services across the hospital and retail sectors, ensuring proof throughout the medication chain of custody.

Executive Insights
Feb 10, 2025

Mark Saxon, the CEO of Safecor Health, discusses the company's strategic plans for 2025, emphasizing their commitment to unit dose drug repackaging and error-free medication delivery. Mark highlights the importance of cultural change and core values such as care, commitment, and excellence in leadership. He expresses excitement about tackling healthcare challenges, cherishes family traditions, and is looking forward to a successful 2025.

Executive Insights
Jan 28, 2025

Venita Abanaka, the Director of Acute Care and Oncology at Parkland Health in Dallas, Texas, is dedicated to serving the underserved in a nearly thousand-bed hospital system. She is focused on redesigning acute care and clinical pharmacy, with an emphasis on automation and networking with vendors and colleagues. Venita values building the next generation of leaders and promotes a culture of servant leadership within her team. Despite challenges like fluid shortages, she views problems as opportunities and maintains a positive relationship with Health Connect Partners.